Healthcare
M1 Kliniken AG(MKLNF)
Live Price
Offline$11.73
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 → Apr 6, 2026
- Market Cap
- $214.81M
- Revenue Growth
- +7.2%
- EPS Growth
- +59.3%
- Dividend Yield
- 2.9%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 198 bars · Jun 23, 2025 → Apr 6, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
M1 Kliniken AG (MKLNF) is a Healthcare stock with a market cap of $214.81M and listed on OTC. The stock last traded around $11.73 and up 0.0% across the available one-year price window (Jun 23, 2025 → Apr 6, 2026). Baseline metrics include revenue growth of +7.2%, EPS growth of +59.3%, a dividend yield of 2.9%. What stands out right now is revenue +7.2%, EPS +59.3%, free cash flow +334.6% with operating margin 8.5% and ROIC 12.4%. The dividend matters to the case here, with a current yield around 2.9%. Valuation is more restrained than many high-expectation growth names at P/E 18.2 and price/sales 0.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines MKLNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+7.2% vs +7.6% peer median
Operating Margin
Below sector median
+8.5% vs +19.4% peer median
P/E
Below sector median
18.2 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +7.2% and EPS at +59.3%, with operating margin around 8.5%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.9%, which matters if the thesis depends on income as much as growth.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
MKLNF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
MKLNF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MKLNF and SPY.
Company Overview
M1 Kliniken AG
Other OTC
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.
- Leadership
- Kilian Brenske
- IPO Date
- Feb 19, 2021
- Employees
- 366
- Street Address
- Grünauer Strasse 5
- Mailing
- Berlin, 12557
- Region
- Berlin, DE
- Reporting Currency
- USD
- Investor Line
- 49 30 347 47 44 14
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 18.2
- EV/EBITDA
- 9.0
- Price/Sales
- 0.9
- Price/Book
- 2.7
Growth
- Revenue
- +7.2%
- EPS
- +59.3%
- Free Cash Flow
- +334.6%
Profitability
- Gross Margin
- 12.0%
- Operating Margin
- 8.5%
- Net Margin
- 5.0%
- ROE
- 15.8%
- ROIC
- 12.4%
Balance Sheet
- Debt/Equity
- 0.18
- Current Ratio
- 2.06
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.